secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-08-14T20:15:56+00:00
Accession:  0001493152-26-038391
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative suspends ExoCR and BioX product shipments pending regulatory review
--------------------------------------------------------------------------------

- Suspended all orders and shipments of ExoCR and BioX biocosmeceutical product lines effective August 7, 2026.
- Suspension pending business review and regulatory assessment of documentation, sourcing, and regulatory status.
- Company has not decided to discontinue these product lines.
- Review could result in costs, need for additional capital, and uncertainty about resuming sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000149315226038391/0001493152-26-038391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000149315226038391/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer